Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ
Closed
Oct 8, 2026
Day's Range
34.8552 wk Range
22.95Profile - INDV - Indivior Pharmaceuticals, Inc.
Profile
Mic Code
XNGS
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
827
Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on medicines for opioid use disorder and related substance use disorders. The company develops, manufactures, and markets buprenorphine-based prescription treatments designed to support recovery and long-term disease management in clinical settings. Its product portfolio includes branded therapies such as SUBLOCADE, SUBOXONE Film, SUBOXONE Tablet, and SUBUTEX, which are used in addiction medicine and office-based treatment programs. Indivior serves patients, healthcare professionals, and treatment providers across the United States and other international markets, with a business centered on evidence-based care for chronic addiction conditions. The company also supports broader understanding of addiction medicine through clinical research, medical education, and treatment access initiatives. Headquartered in North Chesterfield, Virginia, Indivior plays a specialized role in the pharmaceutical market as a dedicated provider of addiction treatment therapies.
Profile Details
Type
Common Stock
Address
10710 Midlothian Turnpike
City
North Chesterfield
State
VA
Zip
23235
Country
United States
Phone
804 379 1040
Key Executives - INDV - Indivior Pharmaceuticals, Inc.
Key executives
Cross Listings - INDV - Indivior Pharmaceuticals, Inc.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
